Open Nav

Anna French, PhD


Qiming Venture Partners USA

Anna is a Principal at Qiming Venture Partners USA, focused on healthcare investing. Since joining Qiming in 2017, Anna has led or been actively involved in investments in WindMIL Therapeutics, Let’s Get Checked and Kezar Life Sciences (NASDAQ: KZR). She serves on the board of WindMIL Therapeutics and is a board observer with Let’s Get Checked and Platelet Biogenesis.

Prior to joining Qiming, Anna was a management consultant at the Boston Consulting Group (BCG) where she advised leading biopharma companies on their strategy and operations. She also led a global industry-academic consortium focused on cell therapy commercialization. Anna earned a D.Phil from the University of Oxford, UK where her research focused on hematological differentiation of human induced pluripotent stem (iPS) cells. Anna has over 20 publications in the field of stem cell research.

This speaker's sessions: